Aliphatic Hydrocarbon Solvents and Thinners Market
This report contains market size and forecasts of Aliphatic Hydrocarbon Solvents and Thinners in ... Read More
1 Introduction to Research & Analysis Reports 1.1 Pharmaceutical Contract Development and Manufacturing Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Pharmaceutical Contract Development and Manufacturing Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Pharmaceutical Contract Development and Manufacturing Overall Market Size 2.1 Global Pharmaceutical Contract Development and Manufacturing Market Size: 2021 VS 2028 2.2 Global Pharmaceutical Contract Development and Manufacturing Market Size, Prospects & Forecasts: 2017-2028 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Pharmaceutical Contract Development and Manufacturing Players in Global Market 3.2 Top Global Pharmaceutical Contract Development and Manufacturing Companies Ranked by Revenue 3.3 Global Pharmaceutical Contract Development and Manufacturing Revenue by Companies 3.4 Top 3 and Top 5 Pharmaceutical Contract Development and Manufacturing Companies in Global Market, by Revenue in 2021 3.5 Global Companies Pharmaceutical Contract Development and Manufacturing Product Type 3.6 Tier 1, Tier 2 and Tier 3 Pharmaceutical Contract Development and Manufacturing Players in Global Market 3.6.1 List of Global Tier 1 Pharmaceutical Contract Development and Manufacturing Companies 3.6.2 List of Global Tier 2 and Tier 3 Pharmaceutical Contract Development and Manufacturing Companies 4 Market Sights by Product 4.1 Overview 4.1.1 by Type - Global Pharmaceutical Contract Development and Manufacturing Market Size Markets, 2021 & 2028 4.1.2 Pharmaceutical Manufacturing Services 4.1.3 Biologics Manufacturing Services 4.1.4 Drug Development Services 4.2 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue & Forecasts 4.2.1 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2022 4.2.2 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2023-2028 4.2.3 By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Pharmaceutical Contract Development and Manufacturing Market Size, 2021 & 2028 5.1.2 Big Pharma 5.1.3 Small Pharma 5.1.4 Generic Pharma 5.1.5 CRO 5.2 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue & Forecasts 5.2.1 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2022 5.2.2 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2023-2028 5.2.3 By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 6 Sights by Region 6.1 By Region - Global Pharmaceutical Contract Development and Manufacturing Market Size, 2021 & 2028 6.2 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue & Forecasts 6.2.1 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2022 6.2.2 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue, 2023-2028 6.2.3 By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 6.3 North America 6.3.1 By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028 6.3.2 US Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.3.3 Canada Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.3.4 Mexico Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.4 Europe 6.4.1 By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028 6.4.2 Germany Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.4.3 France Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.4.4 U.K. Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.4.5 Italy Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.4.6 Russia Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.4.7 Nordic Countries Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.4.8 Benelux Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.5 Asia 6.5.1 By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028 6.5.2 China Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.5.3 Japan Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.5.4 South Korea Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.5.5 Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.5.6 India Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.6 South America 6.6.1 By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028 6.6.2 Brazil Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.6.3 Argentina Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028 6.7.2 Turkey Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.7.3 Israel Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.7.4 Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 6.7.5 UAE Pharmaceutical Contract Development and Manufacturing Market Size, 2017-2028 7 Players Profiles 7.1 Thermo Fisher Scientific Inc. 7.1.1 Thermo Fisher Scientific Inc. Corporate Summary 7.1.2 Thermo Fisher Scientific Inc. Business Overview 7.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.1.4 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.1.5 Thermo Fisher Scientific Inc. Key News 7.2 Catalent, Inc. 7.2.1 Catalent, Inc. Corporate Summary 7.2.2 Catalent, Inc. Business Overview 7.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.2.4 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.2.5 Catalent, Inc. Key News 7.3 Lonza Group Ltd 7.3.1 Lonza Group Ltd Corporate Summary 7.3.2 Lonza Group Ltd Business Overview 7.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.3.4 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.3.5 Lonza Group Ltd Key News 7.4 Recipharm AB 7.4.1 Recipharm AB Corporate Summary 7.4.2 Recipharm AB Business Overview 7.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.4.4 Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.4.5 Recipharm AB Key News 7.5 Vetter Pharma International GMBH 7.5.1 Vetter Pharma International GMBH Corporate Summary 7.5.2 Vetter Pharma International GMBH Business Overview 7.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.5.4 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.5.5 Vetter Pharma International GMBH Key News 7.6 FAMAR Health Care Services 7.6.1 FAMAR Health Care Services Corporate Summary 7.6.2 FAMAR Health Care Services Business Overview 7.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.6.4 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.6.5 FAMAR Health Care Services Key News 7.7 AbbVie Inc. 7.7.1 AbbVie Inc. Corporate Summary 7.7.2 AbbVie Inc. Business Overview 7.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.7.4 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.7.5 AbbVie Inc. Key News 7.8 Aenova Group 7.8.1 Aenova Group Corporate Summary 7.8.2 Aenova Group Business Overview 7.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.8.4 Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.8.5 Aenova Group Key News 7.9 Consort Medical plc 7.9.1 Consort Medical plc Corporate Summary 7.9.2 Consort Medical plc Business Overview 7.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.9.4 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.9.5 Consort Medical plc Key News 7.10 Almac Group 7.10.1 Almac Group Corporate Summary 7.10.2 Almac Group Business Overview 7.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.10.4 Almac Group Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.10.5 Almac Group Key News 7.11 Siegfried Holding AG 7.11.1 Siegfried Holding AG Corporate Summary 7.11.2 Siegfried Holding AG Business Overview 7.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.11.4 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.11.5 Siegfried Holding AG Key News 7.12 Boehringer Ingelheim International GmbH 7.12.1 Boehringer Ingelheim International GmbH Corporate Summary 7.12.2 Boehringer Ingelheim International GmbH Business Overview 7.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.12.4 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.12.5 Boehringer Ingelheim International GmbH Key News 7.13 Evonik Industries AG 7.13.1 Evonik Industries AG Corporate Summary 7.13.2 Evonik Industries AG Business Overview 7.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Major Product Offerings 7.13.4 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue in Global Market (2017-2022) 7.13.5 Evonik Industries AG Key News 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer
List of Tables Table 1. Pharmaceutical Contract Development and Manufacturing Market Opportunities & Trends in Global Market Table 2. Pharmaceutical Contract Development and Manufacturing Market Drivers in Global Market Table 3. Pharmaceutical Contract Development and Manufacturing Market Restraints in Global Market Table 4. Key Players of Pharmaceutical Contract Development and Manufacturing in Global Market Table 5. Top Pharmaceutical Contract Development and Manufacturing Players in Global Market, Ranking by Revenue (2021) Table 6. Global Pharmaceutical Contract Development and Manufacturing Revenue by Companies, (US$, Mn), 2017-2022 Table 7. Global Pharmaceutical Contract Development and Manufacturing Revenue Share by Companies, 2017-2022 Table 8. Global Companies Pharmaceutical Contract Development and Manufacturing Product Type Table 9. List of Global Tier 1 Pharmaceutical Contract Development and Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share Table 10. List of Global Tier 2 and Tier 3 Pharmaceutical Contract Development and Manufacturing Companies, Revenue (US$, Mn) in 2021 and Market Share Table 11. By Type – Global Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2021 & 2028 Table 12. By Type - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2017-2022 Table 13. By Type - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2023-2028 Table 14. By Application – Global Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2021 & 2028 Table 15. By Application - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2017-2022 Table 16. By Application - Pharmaceutical Contract Development and Manufacturing Revenue in Global (US$, Mn), 2023-2028 Table 17. By Region – Global Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2021 & 2028 Table 18. By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), 2017-2022 Table 19. By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), 2023-2028 Table 20. By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022 Table 21. By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028 Table 22. By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022 Table 23. By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028 Table 24. By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022 Table 25. By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028 Table 26. By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022 Table 27. By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028 Table 28. By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2022 Table 29. By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2023-2028 Table 30. Thermo Fisher Scientific Inc. Corporate Summary Table 31. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product Offerings Table 32. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 33. Catalent, Inc. Corporate Summary Table 34. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product Offerings Table 35. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 36. Lonza Group Ltd Corporate Summary Table 37. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product Offerings Table 38. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 39. Recipharm AB Corporate Summary Table 40. Recipharm AB Pharmaceutical Contract Development and Manufacturing Product Offerings Table 41. Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 42. Vetter Pharma International GMBH Corporate Summary Table 43. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product Offerings Table 44. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 45. FAMAR Health Care Services Corporate Summary Table 46. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product Offerings Table 47. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 48. AbbVie Inc. Corporate Summary Table 49. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product Offerings Table 50. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 51. Aenova Group Corporate Summary Table 52. Aenova Group Pharmaceutical Contract Development and Manufacturing Product Offerings Table 53. Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 54. Consort Medical plc Corporate Summary Table 55. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product Offerings Table 56. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 57. Almac Group Corporate Summary Table 58. Almac Group Pharmaceutical Contract Development and Manufacturing Product Offerings Table 59. Almac Group Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 60. Siegfried Holding AG Corporate Summary Table 61. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product Offerings Table 62. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 63. Boehringer Ingelheim International GmbH Corporate Summary Table 64. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product Offerings Table 65. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) Table 66. Evonik Industries AG Corporate Summary Table 67. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product Offerings Table 68. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue (US$, Mn), (2017-2022) List of Figures Figure 1. Pharmaceutical Contract Development and Manufacturing Segment by Type in 2021 Figure 2. Pharmaceutical Contract Development and Manufacturing Segment by Application in 2021 Figure 3. Global Pharmaceutical Contract Development and Manufacturing Market Overview: 2021 Figure 4. Key Caveats Figure 5. Global Pharmaceutical Contract Development and Manufacturing Market Size: 2021 VS 2028 (US$, Mn) Figure 6. Global Pharmaceutical Contract Development and Manufacturing Revenue, 2017-2028 (US$, Mn) Figure 7. The Top 3 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue in 2021 Figure 8. By Type - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 Figure 9. By Application - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 Figure 10. By Region - Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 Figure 11. By Country - North America Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 Figure 12. US Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 13. Canada Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 14. Mexico Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 15. By Country - Europe Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 Figure 16. Germany Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 17. France Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 18. U.K. Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 19. Italy Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 20. Russia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 21. Nordic Countries Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 22. Benelux Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 23. By Region - Asia Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 Figure 24. China Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 25. Japan Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 26. South Korea Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 27. Southeast Asia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 28. India Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 29. By Country - South America Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 Figure 30. Brazil Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 31. Argentina Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 32. By Country - Middle East & Africa Pharmaceutical Contract Development and Manufacturing Revenue Market Share, 2017-2028 Figure 33. Turkey Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 34. Israel Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 35. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 36. UAE Pharmaceutical Contract Development and Manufacturing Revenue, (US$, Mn), 2017-2028 Figure 37. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 38. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 39. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 40. Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 41. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 42. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 43. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 44. Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 45. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 46. Almac Group Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 47. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 48. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 49. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
67
This report contains market size and forecasts of Aliphatic Hydrocarbon Solvents and Thinners in ... Read More
This report contains market size and forecasts of Crop Oil Concentrates in global, including the ... Read More
This report contains market size and forecasts of Feed Anticoccidials in global, including the fo ... Read More
This report contains market size and forecasts of Portable Filtration System in global, including ... Read More